top of page
shutterstock_1165031944.jpg

News

September 2019

  • andreachicca797
  • Sep 14, 2018
  • 1 min read

Updated: Jan 8

Synendos Therapeutics was selected for BaseLaunch Phase I and received CHF 10'000.

https://www.baselaunch.ch/portfolio/


bottom of page